The Ewing sarcoma is the second most common bone tumor in children and young adults. Despite the advances in therapy, the 5-year survival rate for patients with metastatic disease is poor, indicating the need for alternative treatments. Here, we report that 2-methoxyestradiol (2-Me), a natural estrogen metabolite, induced a caspase-dependent apoptosis of Ewing sarcoma-derived cells independently of their p53 status. 2-Me-induced apoptosis occurred through the mitochondrial death pathway as evidenced by reduction of the mitochondrial transmembrane potential, cytochrome c release and caspase-9 activation. Treatment of cells with 2-Me resulted in generation of intracellular H 2 O 2 , which occurred earlier than caspase-9 activation. The H 2 O 2 -reducing agent Ebselen and the lipid peroxidation inhibitor vitamin E decreased both 2-Me-induced caspase-9 activation and cell death, thus providing evidence for a role of H 2 O 2 and lipid peroxides in the initiation of this process. Rotenone, an inhibitor of the mitochondrial respiratory chain, abolished both apoptosis and H 2 O 2 production, thereby identifying mitochondria as the source of H 2 O 2 . Moreover, we observed that treatment of cells with 2-Me or H 2 O 2 induced activation of the c-Jun N-terminal kinase (JNK). Overexpression of a dominantnegative mutant of JNK1 reduced 2-Me-induced apoptosis indicating that JNK participates in this process. Altogether, our results provide evidence that 2-Me triggers apoptosis of Ewing sarcoma cells through induction of a mitochondria redox-dependent mechanism and suggest that this compound or other agents that selectively increase the level of reactive oxygen species may prove useful to the development of novel strategies for treatment of Ewing tumors.
Introduction
The highly malignant Ewing sarcoma belongs to a family of small-round-cell tumors that develop in bone and soft tissues of children and young adults (Kovar, 1998) . Over 90% of Ewing tumors have recurrent reciprocal translocations that join the EWS gene on chromosome 22 to an ETS family gene, either FLI-1 on chromosome 11 or ERG on chromosome 21 (Delattre et al., 1992; Sorensen et al., 1994) . The resulting chimeric proteins function as sequence-specific transcription factors and appear to be essential for maintaining the oncogenic properties of tumor cells (Kovar, 1998) . Combination therapies associated with local surgery or ionizing radiation are standard practices in the treatment of patients with Ewing sarcoma (Kushner and Meyers, 2001; Oberlin et al., 2001) . However, the 5-year survival rate of patients with metastasis at diagnosis of the disease is poor, thus emphasizing the need for novel therapeutic strategies (Pinkerton et al., 2001) .
2-Methoxyestradiol (2-Me), a physiological metabolite of 17b-estradiol that cannot bind the estrogen receptor, has recently emerged as a promising anticancer agent (Pribluda et al., 2000) . It is orally active at inhibiting tumor growth and metastatic spreading in several tumor models, at doses showing no clinical signs of toxicity (Fotsis et al., 1994; Schumacher and Neuhaus, 2001 ). These effects have been linked to its ability to inhibit angiogenesis and to induce apoptosis of tumor cells (Mukhopadhyay and Roth, 1997; Yue et al., 1997; Qadan et al., 2001) Many cellular responses to 2-Me treatment have been described, including accumulation of cells in G2/M phase, formation of reactive oxygen species (ROS), inhibition of tubulin polymerization, activation of c-jun N-terminal-activated kinase (JNK), increased expression of FAS, p53 and p21 WAF1 , Bcl-2 phosphorylation and mitochondrial release of cytochrome c (Hamel et al., 1996; Mukhopadhyay and Roth, 1997; Yue et al., 1997; Attalla et al., 1998; Huang et al., 2000; Lin et al., 2000; Kumar et al., 2001; Qadan et al., 2001; Qanungo et al., 2002) . However, little is known about the molecular events implicated in the ability of 2-Me to initiate the apoptotic cascade.
Apoptosis can be initiated mainly by two pathways: the mitochondria-mediated and the death receptormediated pathways (Gupta, 2000; Reed, 2000) . The apoptotic death receptor pathway is initiated following the binding of a specific ligand to a TNF receptor superfamily member (Fas, TNF RI, TNF RII, Trail, DR4, DR5). This binding is followed by the recruitment of the adaptor molecule FAS-associated death domain (FADD). Subsequently, FADD uses its death effector domain to recruit the proximal caspases-8 or -10. This results in the formation of a death initiator signaling complex with subsequent release of the activated forms of these caspases. Activation of caspase-8 or -10, in turn, triggers activation of executor caspases, which mediate cell death (Ashkenazi and Dixit, 1998; Sartorius et al., 2001) . Activation of the mitochondrial pathway is initiated by several changes in mitochondrial function including an increase in mitochondrial membrane permeability, a decrease in mitochondrial membrane potential, a release of cytochrome c and of the apoptosis inducing factor. Interaction of the released cytochrome c with dATP and APAF-1 results in the activation of the initiator caspase, caspase-9, which in turn triggers activation of executor caspases of cell death (Ferri and Kroemer, 2000; Reed and Green, 2002) . Mitochondria are also known to be a major source of ROS (Szibor et al., 2001; Curtin et al., 2002) , that is, superoxide (O 2 À ), hydrogen peroxide (H 2 O 2 ) and hydroxyl radical (OH ), which have been implicated as mediators of apoptosis in response to several anti-cancer drugs (Cai and Jones, 1999; Simon et al., 2000; Benhar et al., 2001; Fleury el al., 2002; Kotamraju et al., 2002; Nakamura et al., 2002) . It has been shown that apoptosis occurs when the amount of ROS produced in cells cannot be handled by radical-scavenging cellular antioxidants. This results in peroxidation of membrane lipids, cleavage of DNA and oxidation of proteins (Halliwell and Gutteridge, 1984) .
In the present study, we investigated the ability of 2-Me to kill Ewing sarcoma-derived cells. We found that 2-Me induced a caspase-dependent apoptosis in these cells independently of their p53 status. Moreover, we present evidence that the initial event in the mechanism of action of 2-Me is the induction of H 2 O 2 production by the mitochondria, which leads to the activation of both initiator caspases, caspase-9 and -8.
Results

2-Me inhibits cell proliferation through induction of apoptosis in Ewing sarcoma cell lines
We first examined the effect of 2-Me on the proliferation of six Ewing sarcoma-derived cell lines. As shown in Figure 1a , treatment with 10 mm 2-Me resulted in a complete inhibition of the proliferation of the six cell lines. This effect occurred independently of the function of the p53 protein, since similar responses were observed in cells expressing no p53 (SK-NMC), wild-type p53 (EW7, EW24 and COH) or mutated p53 (EW1 and ORS). Treatment of cells with 2-Me also resulted in a dose-dependent manner in two features of apoptosis, that is, condensation and fragmentation of nuclei (Figure 1b, left panel) . Apoptotic phenotype was confirmed by detection of nucleosomal DNA fragmentation ( Figure 1b , right panel) and externalization of phosphatidylserine at the outer leaflet of the plasma membrane ( Figure 1c) . Like its inhibitory effect on cell proliferation, the apoptotic effect of 2-Me was indepen- 2-Me-induced apoptosis and reactive oxygen species M Djavaheri et al dent of p53 status, since condensation of nuclei and DNA fragmentation were induced to a similar extent in EW7 (p53-positive) cells and SK-NMC (p53-negative) cells (Figure 1d ).
2-Me-induced apoptosis requires caspase activation
With the aim of investigating the mechanisms implicated in 2-Me-induced apoptosis, we first examined whether this treatment induced the activation of caspases. As shown in Figure 2a , treatment of cells with 2-Me resulted in the early activation of the initiator caspases, caspase-9 and -8, as indicated by the appearance of cleavage products from the corresponding pro-caspases (p37/p35 kDa for procaspase-9 and p43/p41 kDa for pro-caspase-8). We also found that treatment of EW7 cells with the broad-spectrum caspase inhibitor ZVAD-FMK completely inhibited 2-Me-induced nucleosomal DNA fragmentation in EW7 cells after 24 h of treatment ( Figure 2b ). However, Z-VAD-FMK only delayed cell death since we observed that after 48 h of treatment of cells with 2-Me in the presence of Z-VAD-FMK, the cells died through a non-apoptotic mechanism as revealed by trypan blue exclusion assay and Hoechst 33258 staining (data not shown). Addition of specific inhibitors of caspase-9 (LEHD-FMK) or of caspase-8 (IEDT-FMK), resulted in a 57 and 44% decrease in 2-Me-induced DNA fragmentation, respectively, thus showing that both caspases participated in 2-Meinduced apoptosis. We then investigated whether the two caspases were activated independently or whether activation of one of them was necessary to the activation of the other. As shown in Figure 2c , the caspase-9 inhibitor (LEHD-FMK), significantly reduced 2-Meinduced caspase-8 activation. Inversely, we observed that inhibition of caspase-8 activity by IEDT-FMK did not affect 2-Me-induced caspase-9 activation (not shown). This indicates that caspase-9 activation is an initial event that precedes caspase-8 activation. The use of specific inhibitors of caspase-3 and -6 revealed that these executor caspases were also implicated in 2-Meinduced apoptosis (not shown).
Effect of 2-Me on the expression of death receptors and death receptor ligands Apoptosis induced by 2-Me could be the consequence of the induction of the expression of death receptors and/ or their ligands in response to 2-Me. To test this hypothesis, we used the RNase protection analysis (RPA) technique with a template set containing specific probes for a variety of genes coding for TRADD, TNFRp55, Trail, DR4, DR5, DR3, DCR1, Fas and FasL. As shown in Figure 3 , the only gene whose expression was increased after treatment of EW7 cells with 2-Me was Fas. This induction required a relatively long time of exposure (>12 h), and thus could not be responsible for the activation of caspase-9 and -8, which were already present after 12 h of treatment. No change was observed in the expression of the other death receptors or their ligands.
2-Me-induced activation of the mitochondrial death pathway
The belated induction of Fas gene expression compared to earlier activation of caspase-9 by 2-Me implies a minor role for death receptors in the initiation step of apoptosis induced by 2-Me, arguing in favor of a role of the mitochondrial death pathway. Mitochondrial release of cytochrome c is an early step in this pathway (Reed and Green, 2002) . To investigate whether 2-Me induced such a response, the level of cytosolic cytochrome c was measured by immunoblot analysis. As shown in Figure 4a , the cytosolic fraction of untreated cells did . To examine whether 2-Me induced such a transition, cells were treated with 3,3 0 -dihexylocarbocyamine iodide (DiOC6(3)), a fluorescent dye that accumulates in the mitochondrial matrix under the influence of the DC m . As shown in Figure 4b , a reduction in the DC m was observed in 2-Me-treated EW7 cells as compared to control cells. The loss of (DC m ) induced by 2-Me was observed in both propidium iodide-positive and propidium iodide-negative cells (data not shown). Similar results have been found with others proapoptotic agents (Castedo et al., 2002) .
2-Me-induced cell death is inhibited by antioxidants
Generation of ROS upon activation of mitochondria has been shown to induce apoptosis in different cell systems (Cai and Jones, 1999; Curtin et al., 2002) . We therefore investigated whether 2-Me signals apoptosis through ROS production. To test this possibility, we examined the effect of distinct antioxidants/ROS scavengers on 2-Me-induced apoptosis in EW7 cells. The following antioxidants were used: N-acetyl-l-cysteine (Nac) (Curtin et al., 2002) , which is readily taken up by cells and is rapidly converted to glutathione (GSH); vitamin E (Halliwell and Gutteridge, 1984) , which is a well-known inhibitor of lipid peroxidation; Tiron (Ledenev et al., 1986) , which is a cell-permeable O 2 À scavenger; and Ebselen (Sies, 1994; Zhao et al., 2002) , a seleno-organic component that mimics the activity of the glutathione-peroxidase enzyme by converting H 2 O 2 to H 2 O. As shown in Figure 5a , pretreatment of cells with Ebselen completely prevented 2-Me-induced 2-Me-induced apoptosis and reactive oxygen species M Djavaheri et al apoptosis as assessed by nucleosome DNA fragmentation assay, whereas Nac and Tiron had no effect. This result was also confirmed by chromatin condensation evaluation (not shown). These findings suggest that H 2 O 2 production plays a crucial role in cell death induced by 2-Me and that neither O 2 À nor the redox state of GSH seem to be involved in the mechanism of cell death induced by 2-Me in EW7 cells. In accordance with this hypothesis, we found that treatment of EW7 cells with exogenous H 2 O 2 resulted in induction of apoptosis and this effect was inhibited by a pretreatment of cells with Ebselen ( Figure 5b) . Treatment of cells with vitamin E, a well-known lipid peroxidation chainbreaking antioxidant, also significantly reduced 2-Meinduced apoptosis, suggesting that induction of cell membrane lipid peroxidative damage by 2-Me participated in its apoptotic effect (Figure 5a ).
2-Me generates intracellular H 2 O 2 and lipid peroxidation products
To investigate whether 2-Me induced the production of intracellular H 2 O 2 , we used the nonfluorescent 2 0 ,7 0 -dichlorofluorescein diacetate (DCFH-DA) compound, which is oxidized by H 2 O 2 to yield fluorescent dichlorofluorescein (DCF) (Curtin et al., 2002) . As shown in Figure 6a , treatment of cells with 2-Me resulted in an increase in DCF fluorescence intensity as compared to control cells reflecting intracellular accumulation of H 2 O 2 . This effect was time-dependent and was detectable within 4 h of treatment. As expected, enhancement of DCF fluorescence intensity was inhibited in cells treated with Ebselen before the addition of 2-Me (Figure 6b ). The rise in intracellular H 2 O 2 correlated with the generation of intracellular malondialdehyde (MDA), an end product of lipid peroxidation. As expected, vitamin E inhibited 2-Me-induced lipid peroxidation (Figure 6c ).
2-Me-induced H 2 O 2 production precedes caspase activation
In order to determine whether ROS production preceded caspase-8 and -9 activation, we examined the effect of distinct antioxidants on 2-Me-induced cleavage of these caspases. As shown in Figure 7a , treatment of EW7 cells with Ebselen completely inhibited 2-Meinduced cleavage of both pro-caspases. Moreover, the antioxidant vitamin E partially reduced the cleavage of pro-caspase-8 and -9, thus pointing to a role of lipid peroxidation in induction of this cleavage. In accordance with their inability to inhibit 2-Me-induced DNA fragmentation (Figure 5a ), Nac and Tiron had no effect on the cleavage of the two pro-caspases. As shown in Figure 7b , Ebselen also inhibited cleavage of procaspase-8 and -9 induced by exogenous H 2 O 2 treatment of EW7 cells. Altogether, these results show that generation of H 2 O 2 is responsible for activation of caspase-8 and -9 during induction of apoptosis by 2-Me.
Mitochondria are involved in induction of both H 2 O 2 production and apoptosis by 2-Me Mitochondria are the major source of oxidants that are generated as a result of a decrease in coupling efficiency during electron transport chain (Szibor et al., 2001) . However, other cellular metabolic components including the NADPH oxidase and the radical-generating enzymes, xanthine/xanthine oxidase and phospholipase A 2 , which activates arachidonic acid metabolism, can generate oxidants in cells (Curtin et al., 2002) . To determine whether mitochondria are the source of H 2 O 2 generated upon treatment of cells with 2-Me, EW7 cells 
Activation of the MAP kinases ERK1/2 and JNK by 2-Me
The mitogen-activated protein kinases (MAPKs), JNKs, p38 MAPKs and extracellular signal-regulated kinases (ERKs) have been implicated as regulators of stressinduced apoptosis in different cell types (Benhar et al., 2001) . We therefore investigated whether treatment of EW7 cells with 2-Me resulted in an activation of these kinases and if so, the role of this activation in 2-Meinduced cell death. For this purpose, cells were treated for different times with 2-Me and subsequently activation of JNK, p38 or ERK was determined by Western blot analysis using antibodies that specifically recognized the phosphorylated forms of these kinases. As shown in Figure 9a , treatment of EW7 cells with 2-Me caused a time-dependent activation of JNK. This activation was detectable after 4 h of treatment, reached a maximum after 16 h and was still present after 24 h. Similarly, 2-Me induced activation of ERK1/2 kinase within 4 h. As previously reported, p38 kinase was constitutively phosphorylated in EW7 cells (Javelaud and Besancon, 2001) , and no further activation was observed upon treatment of these cells with 2-Me. To investigate the role of ERK and JNK activation in 2-Me-induced apoptosis, U0126, a specific inhibitor of ERK activity, and a dominant-negative mutant of JNK were used. Preincubation of cells with U0126, at concentrations (10 and 20 mm) that completely blocked ERK1/2 activity (DeSilva et al., 1998), had no effect on the induction of apoptosis by 2-Me (not shown). In contrast, transfection of cells with a vector encoding a dominant-negative form of JNK1 reduced apoptosis in 2-Me-treated cells as compared to cells transfected with an empty pcDNA vector (Figure 9b ). This result (Benhar et al., 2001; Aoki et al., 2002; Hashimoto et al., 2002) . We therefore investigated whether generation of H 2 O 2 that occurred in 2-Me-treated cells was responsible for JNK activation. As shown in Figure 9c , treatment of EW7 cells with H 2 O 2 resulted in JNK activation. As expected, this activation was abolished in the presence of the H 2 O 2 scavenger, Ebselen. Ebselen also inhibited 2-Me-induced JNK activation (Figure 9c ), thus demonstrating that production of H 2 O 2 occurs upstream of JNK activation in the biochemical cascade triggered by 2-Me to induce apoptosis. In accordance with our results showing that rotenone abolished the rise in intracellular H 2 O 2 level induced by 2-Me, it also inhibited 2-Me-induced JNK activation. To investigate whether JNK activation preceded or was a consequence of caspase activation, cells were treated with the broad-spectrum caspase inhibitor ZVAD-FMK, before addition of 2-Me. As shown in Figure 9c , inhibition of caspase activity by Z-VAD-FMK did not affect JNK activation demonstrating that this activation was not a consequence of caspase activation.
Discussion
In the present study, we provide evidence that 2-Me-induced apoptosis in Ewing sarcoma cells through generation of intracellular H 2 O 2 . This interpretation is based on the rise in intracellular H 2 O 2 level in 2-Metreated EW7 cells and on the marked protection against apoptosis exerted by Ebselen, (Sies, 1994; Zhao et al., 2002) an antioxidant that mimics glutathione peroxidase activity by reducing intracellular accumulation of H 2 O 2 . Furthermore, rotenone, an inhibitor of the mitochondrial respiratory chain, prevented 2-Me-induced apoptosis and H 2 O 2 production, thus implicating the mitochondrial electron transport chain as the source of H 2 O 2 generation. Therefore, our results constitute the first demonstration that 2-Me triggers apoptosis through a mitochondria redox-dependent mechanism.
The idea that ROS play a critical role in apoptotic signal transduction emerged from several observations. Exogenous oxidants, including H 2 O 2 , lipid hydroperoxide end-products, and redox-cycling quinones can trigger apoptosis in a wide range of cell types (Benhar et al., 2001; Ollinger and Kagedal, 2002; Ramachandran et al., 2002; Tang et al., 2002) . Inversely, protection from apoptosis has been shown to be associated with the overexpression of antioxidant enzymes such as mitochondrial glutathione peroxidase (Nomura et al., 2001) and manganese superoxide dismutase (Zhao et al., 2001) or to be induced by pharmacological antioxidants (Kotamraju et al., 2002; Nakamura et al., 2002) . 2-Me-induced ROS production was previously described in hepatoma cells, although no relation between ROS production and 2-Me-induced cell death could be established in this system (Lin et al., 2000) . In contrast, it was shown that treatment of leukemia cells with 2-Me resulted in apoptosis via the generation of superoxide anion O 2 À (Huang et al., 2000) . Our observation that, in Ewing sarcoma cells, Ebselen but not Tiron, an O 2 À scavenger, inhibited 2-Me-induced apoptosis suggests that O 2 À did not participate in the triggering of Ewing sarcoma cell death by 2-Me, probably because it Figure 9 2-Me causes ERK and JNK activation. (a) EW7 cells were treated with 10 mm 2-Me for the indicated times. Cellular extracts were prepared and analysed by Western blot using either polyclonal antiphospho-JNK, antiphospho-ERK or antiphosphop38 antibodies. The blot were stripped and reprobed with either an antibody to JNK1, ERK2 or p38. (b) EW7 cells were transfected with the mutated JNK1 encoding pcDNA vector or the corresponding empty vector together with the pEGFP plasmid. Following a 24 h expression period, cells were left untreated or were treated with 10 mm 2-Me for 16 h before evaluation of chromatin alteration by Hoechst staining. Results are expressed as the percentage of apoptotic cells in the population of GFPexpressing cells and represent the means7s.e.m. of three independent experiments. (c) EW7 cells were first treated with 100 mm Ebs, 50 mm ZVAD-FMK or 6 mm Rot for 2 h prior to treatment with either 10 mm 2-Me for 16 h or 100 mm H 2 O 2 for 8 h. Cellular extracts were prepared and analysed by Western blot using anti-phospho-JNK and anti-JNK1 antibodies 2-Me-induced apoptosis and reactive oxygen species M Djavaheri et al was rapidly converted into H 2 O 2 , which accumulated in cells. H 2 O 2 , although not a free radical, is very harmful to cells because it may cross biological membranes and generate the highly reactive hydroxyl radical OH that can attack lipids, DNA and proteins (Halliwell and Gutteridge, 1984) . We found that treatment of EW7 cells with 2-Me induced the generation of lipid peroxidation end products in cells and that inhibition of lipid peroxidation by vitamin E protected these cells against death induced by 2-Me. Therefore, one proapoptotic molecular target of H 2 O 2 may be oxidized membrane lipids. In accordance with this hypothesis, it has been shown that lipid peroxidation end-products induced cell death in several cell types (Tang et al., 2002) and that peroxidation of the mitochondrial membrane can promote the dissociation of cytochrome c from the mitochondrial inner membrane (Petrosillo et al., 2001 ). However, it should be noted that, besides lipid peroxidation, other ROS-induced effects including oxidation of proteins and damages to DNA are also potential mechanism by which 2-Me may promote apoptosis through generation of H 2 O 2 .
Recent data showing that increased ROS levels correlated with activation of the stress kinase JNK have accumulated (Adler et al., 1999; Benhar et al., 2001 ). Activation of JNK was observed as a consequence of a direct effect of ROS on the JNK-activating kinase ASK1, or of an indirect effect of ROS on redox-sensitive proteins like glutathione-S-transferase P and thioredoxin, which regulate JNK and ASK1 activity, respectively. Moreover, it has been recently reported that JNK activation is linked to the mitochondria death pathway by inactivation of anti-apoptotic Bc12-family proteins (Deng et al., 2001; Aoki et al., 2002) . We found that 2-Me induced a prolonged activation of JNK in EW7 cells. This activation was inhibited by Ebselen, which indicates that production of H 2 O 2 occurs upstream of JNK activation. The use of a dominant-negative form of JNK allowed us to show that this activation participated in induction of cell death in EW7 cells. This result is in accordance with our previous findings showing that induction of apoptosis by TNFa in EW7 cells required a prolonged activation of JNK (Javelaud and Besancon, 2001) . In agreement with our observations, activation of JNK by H 2 O 2 and its role in induction of apoptosis was reported in cardiomyocytes (Aoki et al., 2002) and neuronal cells (Hashimoto et al., 2002) .
We found that 2-Me killed Ewing sarcoma cells through caspase-dependent apoptosis since treatment of cells with the broad-spectrum caspase inhibitor ZVAD-FMK or specific inhibitors of caspase-9 and -8 reduced 2-Me-induced cell death. Activation of these initiator caspases was abolished by treatment of cells with Ebselen or with rotenone, thus showing that production of H 2 O 2 by mitochondria triggered this activation. We also found that 2-Me induced the mitochondrial release of cytochrome c. This release could be because of induction of oxidative damage of mitochondrial membrane by H 2 O 2 , since it has been previously reported that mitochondrial phospholipid peroxidation induced cytochrome c dissociation from submitochondrial particles (Petrosillo et al., 2001) . This suggests that the release of cytochrome c, which is known to be an activator of caspase-9, is an early event in 2-Me-induced apoptosis. Moreover, pretreatment of cells with the caspase-9 inhibitor decreased caspase-8 activation, suggesting that caspase-8 activation was a consequence of caspase-9 activation. Activation of caspase-8 by caspase-9 could occur via caspase-9-mediated caspase-3 activation since the ability of caspase-3 to activate caspase-8 in vitro has been recently demonstrated (Sitailo et al., 2002) .
Altogether, our results suggest the following scenario ( Figure 10 ): accumulation of H 2 O 2 generated by the mitochondria is the initial event in 2-Me-induced apoptosis. Elevated H 2 O 2 levels result in oxidative stress leading to JNK activation, mitochondrial release of cytochrome c and caspase-9 activation, which in turn activates the other initiator caspase, caspase-8. Our results suggest that use of agents that selectively increase the levels of ROS and/or inhibit cellular antioxidant defenses may be a promising approach for the development of new innovative chemotherapeutic treatment of Ewing tumors.
Materials and methods
Reagents, antibodies and plasmids 2-methoxyestradiol, N-acetyl-L-cysteine, 4,5-dihydroxy-1,3-benzene disulfonic acid (Tiron), dl-a-tocopherol (vitamin E), Figure 10 Model for the apoptotic pathways activated by 2-Me in Ewing sarcoma cells. The initial event in 2-Me-induced cell death is the production of H 2 O 2 from mitochondria. This results in JNK activation, mitochondrial release of cytochrome c and caspase-9 activation, which subsequently activates caspase-8. These activations, in turn, trigger activation of executor caspases that mediate cell death 2-Me-induced apoptosis and reactive oxygen species M Djavaheri et al Hoechst 33258 dye, Benzon nuclease, and 2-thiobarbituric acid were purchased from Sigma (St Quentin Fallier, France). The cell-permeable caspase inhibitory peptides Z-VAD-FMK, Z-IETD-FMK and Z-LEHD-FMK were from R&D system, Inc. (Minneapolis, MN, USA). 2-Phenyl-1,2-benzioselenazol-3(2 H)-one (Ebselen) and DiOC6(3) were from Calbiochem (La Jolla, CA, USA). DCFH-DA was from Molecular Probe, Inc. (Leiden, The Netherlands).
The following antibodies were used: monoclonal antibodies against caspase-8 or caspase-9 (Upstate Biotechnology, Lake Placid, NY, USA), cytochrome c (BD Biosciences, Heidelberg, Germany) and actin (ICN Biomedicals, Inc., Costa Mesa, CA, USA), polyclonal serum againt JNK1, p38, ERK, phospho-JNK, phospho-p38 and phospho-ERK (New England Biolabs, Beverly, MA, USA).
The pcDNA vector encoding the dominant-negative mutant of JNK1 has been previously described (Atfi et al., 1997) . The pEGFP vector encoding for the green fluorescent protein (G7P) was from Clontech (Palo Alto, CA, USA).
Cells
Two primary (EW1 and EW7) and three metastatic (EW24, COH and ORS) Ewing sarcoma-derived cell lines were provided by Pr G Lenoir (Universite´Lyon 1) and Dr O Delattre (Institut Curie, Paris) and SK-NMC cells were from ATCC (Parklawn Drive, Rockville, Canada) (Kovar et al., 1993; Dauphinot et al., 2001 ). All these cell lines express the fusion protein EWS-FLI-1. They were grown at 371C in RPMI medium supplemented with 2 mm l-glutamine and 10% fetal calf serum. Cell viablity was determined by the trypan blue dye exclusion method and cell proliferation was assessed by counting cells on a hemocytometer.
Detection of apoptosis
Condensed and fragmented nuclei were detected with Hoechst 33258 fluorescent dye. A total of 300 nuclei were counted for each sample. DNA fragmentation was quantified using a cell death detection kit (Roche Diagnostics GmbH, Mannheim, Germany), which was used according to the manufacturer's instructions.
Phosphatidylserine expressed at the outer leaflet of the plasma membrane was labeled using the Annexin V-FITC kit (MedSystems Diagnostics GmbH, Vienna, Austria), according to the manufacturer's instructions. Cells were then subjected to FACS analysis (FACScan, Becton Dickinson, Heidelberg, Germany).
Variation of the mitochondrial membrane potential (DC m ) during apoptosis was studied using DiOC6(3) as described previously (Djavaheri-Mergny et al., 2001) .
Western blot analysis
Cellular extracts were prepared in 10 mm Tris pH 7.4, 1% SDS, 1 mm sodium vanadate, treated with Benzon nuclease for 5 min at room temperature and boiled for 3 min. Fractions (30 mg) of cellular extract proteins were subjected to SDS-polyacrylamide gel electrophoresis (PAGE) using a Tris/glycine buffer system based on the method of Laemmli. After electrophoresis, proteins were transferred to a nitrocellulose transfer membrane. Blots were then incubated with primary antibodies followed by the appropriate horseradish peroxidase-conjugated secondary antibody. Immunostained proteins were visualized on X-ray film using the enhanced chemiluminescence detection system (Amersham Pharmacia Biotech, Little Chalfont Buckinghamshire, England). The experiments were repeated three times and representative autoradiograms are shown.
Preparation of cytosolic extracts
Cytosolic extracts were obtained using digitonin-based subcellular fractionation as described previously (Ekert et al., 2001) . Briefly, 1.5 Â 10 7 cells were collected and resuspended in 300 ml of cytosolic extraction buffer (250 mm sucrose, 70 mm KCI, 137 mm NaCl, 4.3 mm Na 2 HPO 4 , 1.4 mm KH 2 PO 4 , 1 mm EDTA pH 7.2, 14 mm E64, 130 mm bestatin, 1 mm leupeptin, 0.3 mm aprotinin, 2 mm AEBSF and 200 mg/ml digitonin). Permeabilization of cell plasma membrane was checked by staining cells with 0.03% trypan blue dye. Cell homogenates were then centrifuged at 10 000 g for 5 min at 41C to remove mitochondria from the cytosolic fraction (supernatant). Fractions (22 ml) of this cytosolic fraction were subjected to SDS-PAGE followed by immunoblotting with anti-cytochrome c.
Measurement of ROS production and lipid peroxidation end products
DCFH-DA was used to monitor intracellular H 2 O 2 (Curtin et al., 2002) . Briefly, cells were loaded with 2 mm DCFH-DA for 30 min at 371C. They were then washed with PBS and resuspended in lysis buffer (PBS, 0.1% SDS). DCF fluorescence intensity was measured by using a spectrofluorometer (excitation: 488 nm, emission: 525 nm). For each sample, protein concentration was determined and DCF fluorescence intensity corresponding to 1 mg of protein was calculated.
The lipid peroxidation end products, MDA, was measured as previously described by using the thiobarbituric acid reactive substances (TBARS) assay (Yagi, 1987) . Briefly, 10 7 cells were collected in 2 ml of water. After three cycles of freeze-thawing, the sample was mixed with 0.5 ml of 0.67% (w/v) thiobarbituric acid in water and 0.5 ml of acetic acid, incubated for 1 h at 951C and then centrifuged at 10 000 g for 15 min. The fluorescent TBARS (adducts of MDA) were measured in the supernatants by using a spectrofluorometer (excitation: 515 nm, emission 535 nm). The quantity of MDA produced in cells was determined against a standard curve prepared using tetramethoxypropane. Results were expressed as pmol of MDA equivalents/mg of cellular proteins.
RNase protection assay
Total RNA was extracted with the RNeasy Mini kit (Qiagen, Courtaboeuf, France). RNase protection assays were performed using the hApo-3c Multi-probe Template Set and the RiboQuant Multi-Probe RNase protection Assay System (Pharmingen, San Diego, CA, USA) according to the manufacturer's instructions. Briefly, 4 mg of total RNA and 7 Â 10 5 c.p.m. of [ 32 P]uridine triphosphate were used. After RNase treatment, protected probes were separated on 5% urea-polyacrylamide-bis-acrylamide gels. The gels were dried and exposed to a PhosphoImager screen (Amersham Pharmacia Biotech Europe, Saclay, France).
Transfections
Cells were transfected with either the empty pcDNA3 vector or the vector encoding for mutant JNK1 together with a construct encoding the GFP as previously described (Javelaud and Besancon, 2001 ). The percentage of apoptotic cells among the transfected cells was determined by staining with Hoechst 33258 dye. An average of 300 cells were examined in each experiment.
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